HL Group

#HKU We are a rising lab investigating T cell and myeloid metabolism in chronic inflammatory dieases, and tumour-immune co-evolution

[HL Group @HLGroup2]

Join us now! We’re excited and enthusiastic to have you with us

[HKU Medicine @hkumed]

Are you a PhD student or Postdoc looking to bridge the gap between bench research and clinical application?
Register now for the 2026 Croucher Summer Course in Translational Immunology at HKUMed.

https://t.co/5RN5BJco9S

[HKU Medicine @hkumed]

We are deeply saddened by the loss of life and injuries following the fire at apartment buildings in Tai Po.
Currently, we are working with the Health Bureau to send medical teams to aid our colleagues treating those affected by this tragedy.

[HL Group @HLGroup2]

Neutrophils diversity is truly a sophisticated piece of art! Grasp our standardized neutrophil classification framework from the link below to harmonize research efforts!

https://t.co/u6dKtFh8Sk

[Journal of Experimental Medicine @JExpMed]

This study from Teo, Xue, Ling @HLGroup2 @hkusbms @HKUniversity and colleagues highlights the importance of understanding tumor-associated #neutrophil heterogeneity in cancer to improve therapeutic development. https://t.co/rsCJTOFlAF

#TumorImmunology

[HKU SBMS @hkusbms]

Did you know that high blood sugar levels can weaken immunity in individuals with type 2 diabetes? Report on Professor Heidi Ling and team’s research by The Standard sheds light on this critical health issue.

Check out the full article here: https://t.co/YYS3W4fbUu'

@HLGroup2

[HL Group @HLGroup2]

It’s on today’s news! We’ve made it to the public!

Sometimes, baby steps could foster huge implications.

https://t.co/8hBNtMKLCN

[HL Group @HLGroup2]

It’s online!

Check out our latest work published in @JExpMed ! Seems like there’s so much more to discover in the roles of neutrophils in cancer, they can all be different! Click onto the link below to read more.

https://t.co/c0cRhUbMJQ

[HL Group @HLGroup2]

Our recent paper on immune defects in patients with Type 2 diabetes has been highlighted in the latest issue of Nature Immunology. Check it out here: https://t.co/wEWxY2gMQi

Our original paper: https://t.co/zolZBZyxI6

[HL Group @HLGroup2]

Our lab’s recent work uncovers why T2D patients are more susceptible to severe viral infections
Check it out here: https://t.co/uQ45o9Ta8M

[Journal of Experimental Medicine @JExpMed]

This year, we continue to highlight #WomenInScience by amplifying their voices. Hear from a cross section of women, across multiple research fields, discussing their science & the process of setting up a lab as an independent researcher: https://t.co/xnW6TC2I5C

[HL Group @HLGroup2]

T細胞耗竭 削抗癌作用 港大揪元兇 - Yahoo新聞

https://t.co/ckRAEWhWzK

[HL Group @HLGroup2]

HL Group is recruiting a Post-doctoral Fellow to investigate the link between metabolic reprogramming and immune evasion in solid cancer. Enquiries of about the duties of the post should be sent to Dr. Heidi Ling at [email protected].
https://t.co/ba2Qs3fXjH

[HL Group @HLGroup2]

We are excited to share our work at #BSI22! Come to P633 and check out our insights into the development of CD8+ T cell exhaustion in #CancerResearch and our #immunotherapy benefits
Many thanks to @bsicongress for organizing this opportunity.

[HL Group @HLGroup2]

Check out our latest paper in Cell Reports about the double-edge effects of Type I interferons on T cell exhaustion, and its impact on cancer therapy resistance. Thanks to the authors involved. @stephaniema912 @YuanhuaHuang @CellReports
https://t.co/mZayfhsjD2

[HL Group @HLGroup2]

https://t.co/qdHiW2m1Zo

We are seeking to appoint an enthusiastic and self-motivated Research Assistant to join Dr Heidi G.S. Ling’s group. Information on the research focus is available at https://t.co/dfYmy646aI. Enquiries should be sent to Dr Heidi Ling ([email protected]).

[HL Group @HLGroup2]

We are recruiting a RA to work on translational research projects in investigating the mechanisms of immunotherapy resistance in liver cancer. Interested applicants please apply at
https://t.co/5xAdqsSakx